-+ 0.00%
-+ 0.00%
-+ 0.00%

Peijia Medical wins China NMPA approval for GeminiOne mitral repair system registration

PUBT·09/11/2026 13:31:33
Listen to the news
Peijia Medical wins China NMPA approval for GeminiOne mitral repair system registration
  • Peijia Medical received China NMPA clearance for its GeminiOne transcatheter edge-to-edge repair system registration application.
  • The decision enables commercial entry into mitral regurgitation treatment, expanding its transcatheter valve portfolio beyond aortic indications.
  • EU MDR CE Mark application was submitted; a US early feasibility study remains underway.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Peijia Medical Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260911-12330227), on September 11, 2026, and is solely responsible for the information contained therein.